Global Next Generation Cancer Diagnostics Market Analysis 2013-2018 and Forecast 2019-2024
- 99SLif201918481
- Pages: 97
- December 2018
- Total Views:1155
- Region : Global
- 99Strategy
- Market Research Report

Details
Snapshot
The global Next Generation Cancer Diagnostics market will reach xxx Million USD in 2018 and CAGR xx% 2018-2023. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Next Generation Cancer Diagnostics by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Next Generation Sequencing
qPCR & Multiplexing
DNA Microarrays
Others
Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):
Cepheid
Koninklijke Philips N.V
F. Hoffmann-La Roche Ltd
Qiagen
Novartis AG
Abbott
Thermo Fisher Scientific
Opko Health
Myriad Genetics
Agilent Technologies
GE Healthcare
PerkinElmer
Genomic Health
Illumina
Hologic
Almac Group
Janssen Global Services
Sysmex Corporation
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Hospitals
Clinics
Others
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Table Of Content
Scope
Table of Content
1 Industry Overview
1.1 Next Generation Cancer Diagnostics Industry
1.1.1 Overview
1.1.2 Development of Next Generation Cancer Diagnostics
1.2 Market Segment
1.2.1 Upstream
1.2.2 Downstream
1.3 Cost Analysis
2 Industry Environment
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Next Generation Cancer Diagnostics Market by Type
3.1 By Type
3.1.1 Next Generation Sequencing
3.1.2 qPCR & Multiplexing
3.1.3 DNA Microarrays
3.1.4 Others
3.2 Market Size
3.3 Market Forecast
4 Major Companies List
4.1 Cepheid (Company Profile, Sales Data etc.)
4.2 Koninklijke Philips N.V (Company Profile, Sales Data etc.)
4.3 F. Hoffmann-La Roche Ltd (Company Profile, Sales Data etc.)
4.4 Qiagen (Company Profile, Sales Data etc.)
4.5 Novartis AG (Company Profile, Sales Data etc.)
4.6 Abbott (Company Profile, Sales Data etc.)
4.7 Thermo Fisher Scientific (Company Profile, Sales Data etc.)
4.8 Opko Health (Company Profile, Sales Data etc.)
4.9 Myriad Genetics (Company Profile, Sales Data etc.)
4.10 Agilent Technologies (Company Profile, Sales Data etc.)
4.11 GE Healthcare (Company Profile, Sales Data etc.)
4.12 PerkinElmer (Company Profile, Sales Data etc.)
4.13 Genomic Health (Company Profile, Sales Data etc.)
4.14 Illumina (Company Profile, Sales Data etc.)
4.15 Hologic (Company Profile, Sales Data etc.)
4.16 Almac Group (Company Profile, Sales Data etc.)
4.17 Janssen Global Services (Company Profile, Sales Data etc.)
4.18 Sysmex Corporation (Company Profile, Sales Data etc.)
5 Market Competition
5.1 Company Competition
5.2 Regional Market by Company
6 Market Demand
6.1 Demand Situation
6.1.1 Demand in Hospitals
6.1.2 Demand in Clinics
6.1.3 Demand in Others
6.2 Regional Demand Comparison
6.3 Demand Forecast
7 Region Operation
7.1 Regional Production
7.2 Regional Market
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
7.3.1.2 by Country (U.S., Canada, Mexico)
7.3.2 Europe
7.3.2.1 Overview
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
7.3.3 Asia-Pacific
7.3.3.1 Overview
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
7.3.4 South America
7.3.4.1 Overview
7.3.4.2 by Country (Brazil, Argentina etc.)
7.3.5 Middle East & Africa
7.3.5.1 Overview
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
7.4 Regional Import & Export
7.5 Regional Forecast
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
9 Research Conclusion
List Of Figure
Figure Next Generation Cancer Diagnostics Industry Chain Structure
Figure Global Next Generation Cancer Diagnostics Market Growth 2013-2018, by Type, in USD Million
Figure North America Next Generation Cancer Diagnostics Market, by Company, in 2018
Figure Europe Next Generation Cancer Diagnostics Market Market, by Company, in 2018
Figure Asia-Pacific Next Generation Cancer Diagnostics Market Market, by Company, in 2018
Figure South America Next Generation Cancer Diagnostics Market Market, by Company, in 2018
Figure Middle East & Africa Next Generation Cancer Diagnostics Market Market, by Company, in 2018
Figure North America Next Generation Cancer Diagnostics Market Size and Growth 2013-2018, in USD Million
Figure Europe Next Generation Cancer Diagnostics Market Size and Growth 2013-2018, in USD Million
Figure Asia-Pacific Next Generation Cancer Diagnostics Market Size and Growth 2013-2018, in USD Million
Figure South America Next Generation Cancer Diagnostics Market Size and Growth 2013-2018, in USD Million
Figure Middle East & Africa Next Generation Cancer Diagnostics Market Size and Growth 2013-2018, in USD Million
Figure Marketing Channels Overview
List Of Table
Table Upstream Segment of Next Generation Cancer Diagnostics
Table Application Segment of Next Generation Cancer Diagnostics
Table Global Next Generation Cancer Diagnostics Market 2013-2024, by Application, in USD Million
Table Major Company List of Next Generation Sequencing
Table Major Company List of qPCR & Multiplexing
Table Major Company List of DNA Microarrays
Table Major Company List of Others
Table Global Next Generation Cancer Diagnostics Market 2013-2018, by Type, in USD Million
Table Global Next Generation Cancer Diagnostics Market Forecast 2019-2024, by Type, in USD Million
Table Cepheid Overview List
Table Next Generation Cancer Diagnostics Business Operation of Cepheid (Sales Revenue, Cost, Gross Margin)
Table Koninklijke Philips N.V Overview List
Table Next Generation Cancer Diagnostics Business Operation of Koninklijke Philips N.V (Sales Revenue, Cost, Gross Margin)
Table F. Hoffmann-La Roche Ltd Overview List
Table Next Generation Cancer Diagnostics Business Operation of F. Hoffmann-La Roche Ltd (Sales Revenue, Cost, Gross Margin)
Table Qiagen Overview List
Table Next Generation Cancer Diagnostics Business Operation of Qiagen (Sales Revenue, Cost, Gross Margin)
Table Novartis AG Overview List
Table Next Generation Cancer Diagnostics Business Operation of Novartis AG (Sales Revenue, Cost, Gross Margin)
Table Abbott Overview List
Table Next Generation Cancer Diagnostics Business Operation of Abbott (Sales Revenue, Cost, Gross Margin)
Table Thermo Fisher Scientific Overview List
Table Next Generation Cancer Diagnostics Business Operation of Thermo Fisher Scientific (Sales Revenue, Cost, Gross Margin)
Table Opko Health Overview List
Table Next Generation Cancer Diagnostics Business Operation of Opko Health (Sales Revenue, Cost, Gross Margin)
Table Myriad Genetics Overview List
Table Next Generation Cancer Diagnostics Business Operation of Myriad Genetics (Sales Revenue, Cost, Gross Margin)
Table Agilent Technologies Overview List
Table Next Generation Cancer Diagnostics Business Operation of Agilent Technologies (Sales Revenue, Cost, Gross Margin)
Table GE Healthcare Overview List
Table Next Generation Cancer Diagnostics Business Operation of GE Healthcare (Sales Revenue, Cost, Gross Margin)
Table PerkinElmer Overview List
Table Next Generation Cancer Diagnostics Business Operation of PerkinElmer (Sales Revenue, Cost, Gross Margin)
Table Genomic Health Overview List
Table Next Generation Cancer Diagnostics Business Operation of Genomic Health (Sales Revenue, Cost, Gross Margin)
Table Illumina Overview List
Table Next Generation Cancer Diagnostics Business Operation of Illumina (Sales Revenue, Cost, Gross Margin)
Table Hologic Overview List
Table Next Generation Cancer Diagnostics Business Operation of Hologic (Sales Revenue, Cost, Gross Margin)
Table Almac Group Overview List
Table Next Generation Cancer Diagnostics Business Operation of Almac Group (Sales Revenue, Cost, Gross Margin)
Table Janssen Global Services Overview List
Table Next Generation Cancer Diagnostics Business Operation of Janssen Global Services (Sales Revenue, Cost, Gross Margin)
Table Sysmex Corporation Overview List
Table Next Generation Cancer Diagnostics Business Operation of Sysmex Corporation (Sales Revenue, Cost, Gross Margin)
Table Global Next Generation Cancer Diagnostics Sales Revenue 2013-2018, by Company, in USD Million
Table Global Next Generation Cancer Diagnostics Sales Revenue Share, by Company, in USD Million
Table Next Generation Cancer Diagnostics Demand in Hospitals, 2013-2018, in USD Million
Table Major Consumers in Hospitals
Table Next Generation Cancer Diagnostics Demand in Clinics, 2013-2018, in USD Million
Table Major Consumers in Clinics
Table Next Generation Cancer Diagnostics Demand in Others, 2013-2018, in USD Million
Table Major Consumers in Others
Table Regional Demand Comparison List
Table Major Application in Different Regions
Table Next Generation Cancer Diagnostics Demand Forecast 2019-2024, by Application, in USD Million
Table Next Generation Cancer Diagnostics Production 2013-2018, by Region, in USD Million
Table Global Next Generation Cancer Diagnostics Market 2013-2018, by Region, in USD Million
Table Global Next Generation Cancer Diagnostics Market Share 2013-2018, by Region, in USD Million
Table North America Next Generation Cancer Diagnostics Market Size 2013-2018, by Country, in USD Million
Table Europe Next Generation Cancer Diagnostics Market Size 2013-2018, by Country, in USD Million
Table Asia-Pacific Next Generation Cancer Diagnostics Market Size 2013-2018, by Country, in USD Million
Table South America Next Generation Cancer Diagnostics Market Size 2013-2018, by Country, in USD Million
Table Middle East & Africa Next Generation Cancer Diagnostics Market Size 2013-2018, by Country, in USD Million
Table Next Generation Cancer Diagnostics Market Forecast 2019-2024, by Region, in USD Million
Table Price Factors List
Licence Rights
"Single User License
allow one user to read, print, and edit the report
Enterprise License
allow all employees within client's company, to read, print, edit the report"
Section Purchase
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Company Profile
Company Profile Title
Snapshot
The global Next Generation Cancer Diagnostics market will reach xxx Million USD in 2018 and CAGR xx% 2018-2023. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Next Generation Cancer Diagnostics by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Next Generation Sequencing
qPCR & Multiplexing
DNA Microarrays
Others
Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):
Cepheid
Koninklijke Philips N.V
F. Hoffmann-La Roche Ltd
Qiagen
Novartis AG
Abbott
Thermo Fisher Scientific
Opko Health
Myriad Genetics
Agilent Technologies
GE Healthcare
PerkinElmer
Genomic Health
Illumina
Hologic
Almac Group
Janssen Global Services
Sysmex Corporation
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Hospitals
Clinics
Others
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Scope
Table of Content
1 Industry Overview
1.1 Next Generation Cancer Diagnostics Industry
1.1.1 Overview
1.1.2 Development of Next Generation Cancer Diagnostics
1.2 Market Segment
1.2.1 Upstream
1.2.2 Downstream
1.3 Cost Analysis
2 Industry Environment
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Next Generation Cancer Diagnostics Market by Type
3.1 By Type
3.1.1 Next Generation Sequencing
3.1.2 qPCR & Multiplexing
3.1.3 DNA Microarrays
3.1.4 Others
3.2 Market Size
3.3 Market Forecast
4 Major Companies List
4.1 Cepheid (Company Profile, Sales Data etc.)
4.2 Koninklijke Philips N.V (Company Profile, Sales Data etc.)
4.3 F. Hoffmann-La Roche Ltd (Company Profile, Sales Data etc.)
4.4 Qiagen (Company Profile, Sales Data etc.)
4.5 Novartis AG (Company Profile, Sales Data etc.)
4.6 Abbott (Company Profile, Sales Data etc.)
4.7 Thermo Fisher Scientific (Company Profile, Sales Data etc.)
4.8 Opko Health (Company Profile, Sales Data etc.)
4.9 Myriad Genetics (Company Profile, Sales Data etc.)
4.10 Agilent Technologies (Company Profile, Sales Data etc.)
4.11 GE Healthcare (Company Profile, Sales Data etc.)
4.12 PerkinElmer (Company Profile, Sales Data etc.)
4.13 Genomic Health (Company Profile, Sales Data etc.)
4.14 Illumina (Company Profile, Sales Data etc.)
4.15 Hologic (Company Profile, Sales Data etc.)
4.16 Almac Group (Company Profile, Sales Data etc.)
4.17 Janssen Global Services (Company Profile, Sales Data etc.)
4.18 Sysmex Corporation (Company Profile, Sales Data etc.)
5 Market Competition
5.1 Company Competition
5.2 Regional Market by Company
6 Market Demand
6.1 Demand Situation
6.1.1 Demand in Hospitals
6.1.2 Demand in Clinics
6.1.3 Demand in Others
6.2 Regional Demand Comparison
6.3 Demand Forecast
7 Region Operation
7.1 Regional Production
7.2 Regional Market
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
7.3.1.2 by Country (U.S., Canada, Mexico)
7.3.2 Europe
7.3.2.1 Overview
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
7.3.3 Asia-Pacific
7.3.3.1 Overview
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
7.3.4 South America
7.3.4.1 Overview
7.3.4.2 by Country (Brazil, Argentina etc.)
7.3.5 Middle East & Africa
7.3.5.1 Overview
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
7.4 Regional Import & Export
7.5 Regional Forecast
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
9 Research Conclusion
List Of Figure
Figure Next Generation Cancer Diagnostics Industry Chain Structure
Figure Global Next Generation Cancer Diagnostics Market Growth 2013-2018, by Type, in USD Million
Figure North America Next Generation Cancer Diagnostics Market, by Company, in 2018
Figure Europe Next Generation Cancer Diagnostics Market Market, by Company, in 2018
Figure Asia-Pacific Next Generation Cancer Diagnostics Market Market, by Company, in 2018
Figure South America Next Generation Cancer Diagnostics Market Market, by Company, in 2018
Figure Middle East & Africa Next Generation Cancer Diagnostics Market Market, by Company, in 2018
Figure North America Next Generation Cancer Diagnostics Market Size and Growth 2013-2018, in USD Million
Figure Europe Next Generation Cancer Diagnostics Market Size and Growth 2013-2018, in USD Million
Figure Asia-Pacific Next Generation Cancer Diagnostics Market Size and Growth 2013-2018, in USD Million
Figure South America Next Generation Cancer Diagnostics Market Size and Growth 2013-2018, in USD Million
Figure Middle East & Africa Next Generation Cancer Diagnostics Market Size and Growth 2013-2018, in USD Million
Figure Marketing Channels Overview
List Of Table
Table Upstream Segment of Next Generation Cancer Diagnostics
Table Application Segment of Next Generation Cancer Diagnostics
Table Global Next Generation Cancer Diagnostics Market 2013-2024, by Application, in USD Million
Table Major Company List of Next Generation Sequencing
Table Major Company List of qPCR & Multiplexing
Table Major Company List of DNA Microarrays
Table Major Company List of Others
Table Global Next Generation Cancer Diagnostics Market 2013-2018, by Type, in USD Million
Table Global Next Generation Cancer Diagnostics Market Forecast 2019-2024, by Type, in USD Million
Table Cepheid Overview List
Table Next Generation Cancer Diagnostics Business Operation of Cepheid (Sales Revenue, Cost, Gross Margin)
Table Koninklijke Philips N.V Overview List
Table Next Generation Cancer Diagnostics Business Operation of Koninklijke Philips N.V (Sales Revenue, Cost, Gross Margin)
Table F. Hoffmann-La Roche Ltd Overview List
Table Next Generation Cancer Diagnostics Business Operation of F. Hoffmann-La Roche Ltd (Sales Revenue, Cost, Gross Margin)
Table Qiagen Overview List
Table Next Generation Cancer Diagnostics Business Operation of Qiagen (Sales Revenue, Cost, Gross Margin)
Table Novartis AG Overview List
Table Next Generation Cancer Diagnostics Business Operation of Novartis AG (Sales Revenue, Cost, Gross Margin)
Table Abbott Overview List
Table Next Generation Cancer Diagnostics Business Operation of Abbott (Sales Revenue, Cost, Gross Margin)
Table Thermo Fisher Scientific Overview List
Table Next Generation Cancer Diagnostics Business Operation of Thermo Fisher Scientific (Sales Revenue, Cost, Gross Margin)
Table Opko Health Overview List
Table Next Generation Cancer Diagnostics Business Operation of Opko Health (Sales Revenue, Cost, Gross Margin)
Table Myriad Genetics Overview List
Table Next Generation Cancer Diagnostics Business Operation of Myriad Genetics (Sales Revenue, Cost, Gross Margin)
Table Agilent Technologies Overview List
Table Next Generation Cancer Diagnostics Business Operation of Agilent Technologies (Sales Revenue, Cost, Gross Margin)
Table GE Healthcare Overview List
Table Next Generation Cancer Diagnostics Business Operation of GE Healthcare (Sales Revenue, Cost, Gross Margin)
Table PerkinElmer Overview List
Table Next Generation Cancer Diagnostics Business Operation of PerkinElmer (Sales Revenue, Cost, Gross Margin)
Table Genomic Health Overview List
Table Next Generation Cancer Diagnostics Business Operation of Genomic Health (Sales Revenue, Cost, Gross Margin)
Table Illumina Overview List
Table Next Generation Cancer Diagnostics Business Operation of Illumina (Sales Revenue, Cost, Gross Margin)
Table Hologic Overview List
Table Next Generation Cancer Diagnostics Business Operation of Hologic (Sales Revenue, Cost, Gross Margin)
Table Almac Group Overview List
Table Next Generation Cancer Diagnostics Business Operation of Almac Group (Sales Revenue, Cost, Gross Margin)
Table Janssen Global Services Overview List
Table Next Generation Cancer Diagnostics Business Operation of Janssen Global Services (Sales Revenue, Cost, Gross Margin)
Table Sysmex Corporation Overview List
Table Next Generation Cancer Diagnostics Business Operation of Sysmex Corporation (Sales Revenue, Cost, Gross Margin)
Table Global Next Generation Cancer Diagnostics Sales Revenue 2013-2018, by Company, in USD Million
Table Global Next Generation Cancer Diagnostics Sales Revenue Share, by Company, in USD Million
Table Next Generation Cancer Diagnostics Demand in Hospitals, 2013-2018, in USD Million
Table Major Consumers in Hospitals
Table Next Generation Cancer Diagnostics Demand in Clinics, 2013-2018, in USD Million
Table Major Consumers in Clinics
Table Next Generation Cancer Diagnostics Demand in Others, 2013-2018, in USD Million
Table Major Consumers in Others
Table Regional Demand Comparison List
Table Major Application in Different Regions
Table Next Generation Cancer Diagnostics Demand Forecast 2019-2024, by Application, in USD Million
Table Next Generation Cancer Diagnostics Production 2013-2018, by Region, in USD Million
Table Global Next Generation Cancer Diagnostics Market 2013-2018, by Region, in USD Million
Table Global Next Generation Cancer Diagnostics Market Share 2013-2018, by Region, in USD Million
Table North America Next Generation Cancer Diagnostics Market Size 2013-2018, by Country, in USD Million
Table Europe Next Generation Cancer Diagnostics Market Size 2013-2018, by Country, in USD Million
Table Asia-Pacific Next Generation Cancer Diagnostics Market Size 2013-2018, by Country, in USD Million
Table South America Next Generation Cancer Diagnostics Market Size 2013-2018, by Country, in USD Million
Table Middle East & Africa Next Generation Cancer Diagnostics Market Size 2013-2018, by Country, in USD Million
Table Next Generation Cancer Diagnostics Market Forecast 2019-2024, by Region, in USD Million
Table Price Factors List
"Single User License
allow one user to read, print, and edit the report
Enterprise License
allow all employees within client's company, to read, print, edit the report"